Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion type Assertion NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_head.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion wasGeneratedBy ECO_0000203 NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion wasDerivedFrom befree-20140225 NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion SIO_000772 21625252 NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion evidence source_evidence_literature NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.
- NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_assertion description "[CDA is involved in gemcitabine inactivation, and there is conflicting data on the role of the non-synonymous CDA Lys²⁷Gln polymorphism in predicting toxicity and survival in cancer patients treated with gemcitabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383649.RADKPAjOrmkRKL9pRKmLhPG9oC0aNgspgBbUyi7Y3nFso130_provenance.